Literature DB >> 23758484

Barriers associated with poor control in Spanish diabetic patients. A consensus study.

M C Carratalá-Munuera1, V F Gil-Guillen, D Orozco-Beltran, J Navarro-Pérez, F Caballero-Martínez, F Alvarez-Guisasola, J García-Soidán, C Fluixá-Carrascosa, J Franch-Nadal, E Martín-Rioboó, L Carrillo-Fernández, S Artola-Menéndez.   

Abstract

BACKGROUND: Delphi technique allows developing a multidisciplinary consensus to establish solutions. AIM: To identify barriers and solutions to improve control in patients with Type-2 Diabetes Mellitus (DM2).
METHODS: An observational study using the 2-round Delphi technique (June-August 2011). A panel of 108 experts in DM2 from medical and nursing fields (primary care providers and specialists) from different regions completed via email a questionnaire with 41 Likert statements and 9 scores for each one. Level of agreement was assessed using measures of central tendency and dispersion. We analysed commonalities/differences between the two groups (Kappa index and McNemar chi-square).
RESULTS: Response rate: 65%. Degree of agreement: 63.4% (95% CI 48.7-78.1%) in medicine, and 78.1% (95% CI 65.4-90.8) in nursing (p > 0.05). Overall level of agreement: Kappa = 0.43, (χ(2) = 2.5 p > 0.05). Regarding non-compliance with therapy, it improves with: the information to the partner/family/caregiver, patient education degree in diabetes, patient motivation and ability to share and agree on decisions with the patient. Clinical inertia improves with: motivation degree of healthcare professionals and the calculation of cardiovascular risk; and gets worse with: the shortage of time in consultation, absence of data in medical record, border high limits measurements accepted as normal readings, lack of a treatment goals, lack of teamwork (Physician/Nurse), scarcity of resources and lack of alarm systems in the electronic medical record on goals to achieve.
CONCLUSION: The participants achieved an agreement in interventions in non-therapeutic compliance and clinical inertia to improve DM2 control.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23758484     DOI: 10.1111/ijcp.12160

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

1.  Family physician clinical inertia in glycemic control among patients with type 2 diabetes.

Authors:  Valerija Bralić Lang; Biserka Bergman Marković; Ksenija Kranjčević
Journal:  Med Sci Monit       Date:  2015-02-05

2.  Basal insulin initiation in primary vs. specialist care: similar glycaemic control in two different patient populations.

Authors:  D Orozco-Beltran; C Pan; A L Svendsen; L Faerch; S Caputo
Journal:  Int J Clin Pract       Date:  2016-02-24       Impact factor: 2.503

3.  Patient Preferences for Pharmacological Diabetes Treatment Among People with Diabetes in Spain: A Discrete Choice Experiment.

Authors:  Fernando Gómez-Peralta; María Mareque; Álvaro Muñoz; Mercedes Maderuelo; Miguel Ángel Casado
Journal:  Diabetes Ther       Date:  2021-11-18       Impact factor: 2.945

4.  Barriers and Solutions to Improve Therapeutic Adherence from the Perspective of Primary Care and Hospital-Based Physicians.

Authors:  Concepción Carratalá-Munuera; Ernesto Cortés-Castell; Emilio Márquez-Contreras; José Maria Castellano; María Perez-Paramo; Adriana López-Pineda; Vicente F Gil-Guillen
Journal:  Patient Prefer Adherence       Date:  2022-03-11       Impact factor: 2.711

5.  What are the development priorities for management of type 2 diabetes by general practitioners in Ningbo, China: a qualitative study of patients' and practitioners' perspectives.

Authors:  Angharad Woolley; Li Li; Josie Solomon; Jialin Li; Kai Huang; Punam Chahal; Priya Chahal; Gloria Tu; Pritpal Chahal; Kaushik Chattopadhyay
Journal:  BMJ Open       Date:  2020-09-10       Impact factor: 2.692

6.  Clinical inertia on insulin treatment intensification in type 2 diabetes mellitus patients of a tertiary public diabetes center with limited pharmacologic armamentarium from an upper-middle income country.

Authors:  Marcelo Alves Alvarenga; William Ricardo Komatsu; Joao Roberto de Sa; Antonio Roberto Chacra; Sergio Atala Dib
Journal:  Diabetol Metab Syndr       Date:  2018-10-29       Impact factor: 3.320

7.  [Adherence of Type 2 Diabetes Mellitus approach: Current situation and possible solutions].

Authors:  Domingo Orozco-Beltrán; Manel Mata-Cases; Sara Artola; Pedro Conthe; Javier Mediavilla; Carlos Miranda
Journal:  Aten Primaria       Date:  2016-01-13       Impact factor: 1.137

8.  [Prospective observational study of insulin detemir in patients with poorly controlled type 2 diabetes mellitus initiating insulin therapy for the first time (SOLVE Study)].

Authors:  Domingo Orozco-Beltrán; Sara Artola-Menéndez
Journal:  Aten Primaria       Date:  2015-06-06       Impact factor: 1.137

9.  Identification of Type 2 Diabetes Management Mobile App Features and Engagement Strategies: Modified Delphi Approach.

Authors:  Hanan A Alenazi; Amr Jamal; Mohammed A Batais
Journal:  JMIR Mhealth Uhealth       Date:  2020-09-11       Impact factor: 4.773

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.